BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26060106)

  • 1. T-cell and B-cell immunity in celiac disease.
    du Pré MF; Sollid LM
    Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease: Autoimmunity in response to food antigen.
    Stamnaes J; Sollid LM
    Semin Immunol; 2015 Sep; 27(5):343-52. PubMed ID: 26603490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.
    Iversen R; Roy B; Stamnaes J; Høydahl LS; Hnida K; Neumann RS; Korponay-Szabó IR; Lundin KEA; Sollid LM
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15134-15139. PubMed ID: 31285344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel, celiac disease and adaptive immunity.
    Sollid LM; Iversen R; Steinsbø Ø; Qiao SW; Bergseng E; Dørum S; du Pré MF; Stamnaes J; Christophersen A; Cardoso I; Hnida K; Chen X; Snir O; Lundin KEA
    Dig Dis; 2015; 33(2):115-121. PubMed ID: 25925911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function of tissue transglutaminase in celiac disease.
    Di Sabatino A; Vanoli A; Giuffrida P; Luinetti O; Solcia E; Corazza GR
    Autoimmun Rev; 2012 Aug; 11(10):746-53. PubMed ID: 22326684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope family.
    Qiao SW; Sollid LM
    Immunogenetics; 2019 Nov; 71(10):665-667. PubMed ID: 31673720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
    du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Detection of Isopeptides between Human Tissue Transglutaminase and Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.